1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [404cc1fa-1d55-487d-94c0-601cc40150a1] => Array ( [runtime-id] => 404cc1fa-1d55-487d-94c0-601cc40150a1 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [931fab61-4d86-41a9-86ff-0b2d9e5a75f4] => Array ( [runtime-id] => 931fab61-4d86-41a9-86ff-0b2d9e5a75f4 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;2712e17a7d696b2cd184c7da03951f914831a748 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [404cc1fa-1d55-487d-94c0-601cc40150a1] => Array ( [runtime-id] => 404cc1fa-1d55-487d-94c0-601cc40150a1 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [931fab61-4d86-41a9-86ff-0b2d9e5a75f4] => Array ( [runtime-id] => 931fab61-4d86-41a9-86ff-0b2d9e5a75f4 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;2712e17a7d696b2cd184c7da03951f914831a748 ) ) )Categorization and distribution of patients with CSF leak identified on GdM
No. of Patients CSF Leak on GdM (% of Patients in Group) Group 1: No CSF leak on CTM with at least 1 imaging study with positive findings Group 1a: Classic brain MR imaging with diffuse dural enhancement and brain sag 14a 2 (17%) Group 1b: Extradural fluid collection on MR spine imaging 2a 1 (50%) Group 2: No CSF leak on CTM with equivocal brain imaging (dural enhancement without brain sag or brain sag without dural enhancement) and negative findings on spine imaging 3 1 (33%) Group 3: No CSF leak on CTM and negative findings on MR brain and spine imaging 6 1 (14%) Group 4: Known CSF leak seen on CTM 17 12 (71%) Total number of patients in groups 1–4 41 17 (41%)
↵a One patient without a leak had both classic brain MR imaging and extradural fluid and is included in both groups 1a and 1b.